MARKET

BIOC

BIOC

Biocept
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.070
0.000
0.00%
After Hours: 4.060 -0.01 -0.25% 19:14 09/24 EDT
OPEN
4.040
PREV CLOSE
4.070
HIGH
4.150
LOW
3.995
VOLUME
237.25K
TURNOVER
--
52 WEEK HIGH
8.38
52 WEEK LOW
3.260
MARKET CAP
59.92M
P/E (TTM)
-34.2881
1D
5D
1M
3M
1Y
5Y
Biocept Implements COVID-19 Testing Program at Select California Community Colleges, Supporting Testing Needs for Students and Staff Amid Pandemic
SAN DIEGO, September 22, 2021--Biocept provides on-campus COVID-19 testing to over 30 California community colleges, as students and staff return to in-person learning.
Business Wire · 4d ago
Biocept Invites You to Join Us at the Benzinga Healthcare Small Cap Conference
Detroit, Michigan--(Newsfile Corp. - September 22, 2021) - Biocept (NASDAQ: BIOC) will be presenting at the Benzinga Healthcare Small Cap Conference being held September 29-30, 2021. We invite our shareholders and all interested parties to explore healthca...
Newsfile · 4d ago
Biocept To Present Data At RAS-Targeted Drug Development Summit Showing Ability Of Its Switch-BlockerTM Technology To Detect Rare Cancer Mutations; Shares Spike Higher
Biocept (NASDAQ:BIOC), a leading provider of molecular diagnostic assays and services, will present data on its Target Selector™ assay formats for the ultra-sensitive detection of KRAS mutations using
Benzinga · 5d ago
Biocept to Present Data at RAS-Targeted Drug Development Summit Showing Ability of Its Switch-Blocker(TM) Technology to Detect Rare Cancer Mutations
Biocept (Nasdaq: BIOC), a leading provider of molecular diagnostic assays and services, will present data on its Target Selector(TM) assay formats for the ultra-sensitive detection of KRAS mutations using Switch-Blocker(TM) technology, which provides advan...
Business Wire · 5d ago
Biocept to Present at Four Virtual Investor Conferences in September
Biocept (Nasdaq: BIOC), a leading provider of molecular diagnostic assays and services, announces that Michael Nall, President and CEO, will present at four upcoming investor conferences as follows:
Business Wire · 09/07 12:00
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, September 01, 2021--Biocept (Nasdaq: BIOC), a leading provider of molecular diagnostic assays and services, today announced that it has granted inducement stock options to purchase an aggregate of 220,800 shares of its common stock to 16 new emp...
Business Wire · 09/01 00:00
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23)
Benzinga · 08/24 12:09
This Analyst Just Made A Massive Upgrade To Their Biocept, Inc. (NASDAQ:BIOC) Earnings Forecasts
Shareholders in Biocept, Inc. ( NASDAQ:BIOC ) may be thrilled to learn that the covering analyst has just delivered a...
Simply Wall St. · 08/22 12:17
More
Forecast
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BIOC. Analyze the recent business situations of Biocept through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BIOC stock price target is 12.00 with a high estimate of 12.00 and a low estimate of 12.00.
EPS
Institutional Holdings
Institutions: 37
Institutional Holdings: 1.61M
% Owned: 10.96%
Shares Outstanding: 14.72M
TypeInstitutionsShares
Increased
6
309.46K
New
7
84.61K
Decreased
4
68.68K
Sold Out
6
127.69K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.61%
Healthcare Equipment & Supplies
-0.42%
Key Executives
Chairman/Director
Samuel Riccitelli
Non-Executive Chairman/Independent Director
Margaret Faye Wilson
President/Chief Executive Officer/Director
Michael Nall
Chief Financial Officer/Chief Operating Officer/Secretary
Timothy Kennedy
Senior Vice President
Michael Dugan
Senior Vice President
Michael Terry
Chief Compliance Officer/General Counsel
Michael Brown
Vice President/Director of Sales
Antonio Paternostro
Other
Gary Marchetti
Other
Tom Nauman
Other
Tim Schofield
Director
David Hale
Director
Antonino Morales
Director
Linda Rubinstein
Independent Director
Marsha Chandler
Independent Director
Bruce Gerhardt
Independent Director
Ivor Royston
No Data
About BIOC
Biocept, Inc. is an early stage molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor nucleic acid, including circulating tumor deoxyribonucleic acid (ctDNA) and circulating tumor ribonucleic acid (ctRNA), assays using a standard blood sample or liquid biopsy. Its blood and cerebrospinal fluid (CSF) assays are intended to provide information to aid healthcare providers by identifying tumor cells associated with progression or metastasis and identifying specific oncogenic alterations that may qualify a subset of cancer patients for targeted therapy. The Company's Target-Selector CTC and molecular platforms provide both biomarker detection as well as monitoring capabilities and require only a patient blood sample or CSF sample to inform treatment decisions. It also offers sensitive polymerase chain reaction (PCR) based assay through Aegea Biotechnologies, Inc. (Aegea) for detecting the COVID-19 virus.

Webull offers kinds of Biocept Inc stock information, including NASDAQ:BIOC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BIOC stock methods without spending real money on the virtual paper trading platform.